Invention Grant
US07829587B2 Substituted 2-aminotetralin derivatives as selective alpha 2B agonist
有权
取代的2-氨基四氢萘衍生物作为选择性α2B激动剂
- Patent Title: Substituted 2-aminotetralin derivatives as selective alpha 2B agonist
- Patent Title (中): 取代的2-氨基四氢萘衍生物作为选择性α2B激动剂
-
Application No.: US11971828Application Date: 2008-01-09
-
Publication No.: US07829587B2Publication Date: 2010-11-09
- Inventor: John R. Cappiello , Dario G. Gomez , Ken Chow , Michael E. Garst , Daniel W. Gil , Larry A. Wheeler
- Applicant: John R. Cappiello , Dario G. Gomez , Ken Chow , Michael E. Garst , Daniel W. Gil , Larry A. Wheeler
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene; John E. Wurst; Kevin J. Forrestal
- Main IPC: C07D213/04
- IPC: C07D213/04 ; A61K31/4402
Abstract:
Substituted 2-aminotetralin derivatives as selective alpha 2B agonists can be incorporated in a pharmaceutical composition and can be used in methods of treating an alpha 2B receptor mediated diseases or conditions. The compounds are represented by Formula 1: wherein R1=H, methyl, ethyl, propyl, or cyclobutyl; R2=methyl or H; R3=pyridinyl X=C or O.
Public/Granted literature
- US20090176845A1 SUBSTITUTED 2-AMINOTETRALIN DERIVATIVES AS SELECTIVE ALPHA 2B AGONIST Public/Granted day:2009-07-09
Information query
